SHENZHEN,China,March 17,2025--MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they are researching CV-QNN (Continuous Variable Quant
READ MOREThe white paper sheds light on the growth and intelligent development trends of the robotic pool cleaning industry and highlights its core driving factors.
Leading energy distributor achieves core-to-edge modernisation with Oracle\'s finance,HR,and workforce solutions to improve efficiency,support renewables,and enhance customer services
BEIJING,Oct. 29,2024-- Shanghai Jiao Tong University (SJTU),as the host of the recently held 10th joint meeting of Sino-foreign cooperative education,showcased its achievements in international cooper
CORRECTION of previous press release - See BACKGROUND facts! GOTHENBURG,Sweden,Oct. 26,2024-- Stena RoRo last week took delivery of E-Flexer No. 11 – in a series of 15 vessels – from the Chinese shi
NEW YORK,Oct. 25,2024-- WeRide,the leading global commercial-stage company,was officially listed on the Nasdaq Global Select Market under the ticker symbol "WRD." Upon listing,WeRide became
GANZHOU,China,Oct. 25,2024-- A report fromJiangxi International Communication Center(JXICC): Zhu Zhiwen,an Olympic Cyclist from Ruijin,Jiangxi delivered a shock to the Paris Olympics. With a bicycle,h
BEIJING,Oct. 25,2024-- On Thursday morning,local time,Chinese PresidentXi Jinping attended the "BRICS Plus" leaders\' dialogue at the Kazan Expo International Exhibition Center,and delivered
HONG KONG,Oct. 25,2024-- UniFab,the world\'s leading AI video enhancement provider,officially releases its latest innovations: 8K upscaling model and slow motion interpolation frames.
NEW YORK,Oct. 25,2024-- ORTUR announces the launch of the H20,a versatile laser engraving machine designed for professional engravers and DIY enthusiasts. The H20 accommodates a wide range of engravin
NANJING,China,Oct. 25,2024-- On October 24,2024,TASTE-2,a Chinese innovative stroke drug study led by Professor WangYongjun from Beijing Tiantan Hospital,was published in an oral report at the 16th Wo
SHANGHAI,Oct. 25,2024-- Recently,ShanghaiMicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 in Australia,a self-develo
- The first tri-party executive roundtable was held in London to strengthen synergies for Seegene\'s vision of creating \'a world free from diseases\'
© OfficialAffairs
